Nexalis Therapeutics Limited (ASX: NX1)
Health Care · Pharmaceuticals · AU
AU$—
— today · — 1Y
Nexalis Therapeutics Limited (ASX: NX1) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.67M.
trading between 0.01 and 0.04.
Tweenvest scores Nexalis Therapeutics Limited across four factors: quality 23/100, value 44/100. Its strongest factor is value.
NX1 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.67M
- Revenue (TTM)
- $736.83K
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- -0.02
- 52-week high
- AU$0.04
- 52-week low
- AU$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 253.04M
- Employees
- —
- Next earnings
- —
About Nexalis Therapeutics Limited
Nexalis Therapeutics Limited, a biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia. The company develops IRX-211 for the management of breakthrough cancer pain and IRX-616a for the treatment of panic disorder, which are inhaled medications delivered through a pressurized metered dose inhaler. It also develops SRX-25 for treatment resistant depression. The company was formerly known as InhaleRx Limited and changed its name to Nexalis Therapeutics Limited in January 2026. Nexalis Therapeutics Limited was incorporated in 2016 and is based in Melbourne, Australia.
- ISIN
- AU0000456733
- Founded
- 2016
- Listed since
- Jan 10, 2017
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eastgate Biotech Corp.OTCPK: ETBI | $2.86M | $0.00 | -46.00% |
| SOHM, Inc.OTCPK: SHMN | $2.81M | $0.00 | +7.78% |
| Clearmind Medicine Inc.NasdaqCM: CMND | $2.77M | $6.58 | 0.00% |
| Lasa Supergenerics LimitedNSEI: LASA | $2.77M | Rs5.32 | -5.00% |
| IM Cannabis Corp.NasdaqCM: IMCC | $2.60M | $1.58 | -22.55% |
| SciSparc Ltd.NasdaqCM: SPRC | $2.60M | $4.47 | -5.30% |
| XORTX Therapeutics Inc.NasdaqCM: XRTX | $2.56M | $1.41 | -17.75% |
| Welcure Drugs and Pharmaceuticals LimitedBSE: 524661 | $2.55M | Rs0.20 | -4.76% |
Figures last refreshed Oct 11, 2026.